The effect of intranasal midazolam on children sedation

Comparison of the efficacy of oral midazolam and intranasal midazolam in sedation for diagnostic procedures (radiology and sonography, CT scan) in children referred to the ED

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171009036661N3

Enrollment

Registered

2018-12-03

Start date

2015-03-21

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatrics Sedation.

Interventions

The first participant in the study is randomly assigned to one of the groups based on randomization table (Appendix 2 below), and the next patient will be assigned so.And no one Knows anything about

Eligibility

Sex/Gender

All

Age

2 Years to 12 Years

Inclusion criteria

Inclusion criteria: age 2 to 12 years old mild to moderate traumatic brain injury no concomitant nasal trauma or nasal anatomic abnormality

Exclusion criteria

Exclusion criteria: 1. Parental dissatisfaction GCS=8 Unstable hemodynamic

Design outcomes

Primary

Measure	Time frame
Sedation Level. Timepoint: 15 minutes after intranasal method and 30 minutes after oral method. Method of measurement: Nialc Wilton Method.	—

Secondary

Measure	Time frame
Parent's level of satisfaction from procedure. Timepoint: After completing procedure. Method of measurement: Questionnare.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Massoud mayel

Kerman University of Medical Sciences

masoud.mayel@gmail.co+98 34 3223 5011

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026